Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Squamous Cell Carcinoma of the Oral Cavity
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Enrollment
- 64
- Locations
- 1
- Primary Endpoint
- Accuracy and Interrater Reliability of HRME Image Interpretation
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
The purpose of this research study is to collect information on whether images made using investigational microscopes can improve researchers' ability to evaluate and distinguish between normal and abnormal areas in tissue samples surgically removed from patients with squamous cell carcinoma. The microscopes being used in this study are considered investigational because they have not been approved by the United States Food and Drug Administration (FDA) for finding abnormal or pre-cancerous areas.
Detailed Description
The overall objective of this exploratory study is to evaluate whether noninvasive fluorescence and reflectance imaging of the upper aerodigestive tract can help clinicians more accurately determine intraoperative margins during ablative cancer surgery. This is an ex vivo study designed to evaluate the feasibility of using prototype optical imaging technology to enhance the discrimination between areas of noncancerous "normal" and cancerous mucosa. The results of this laboratory study will be used to further refine and develop this technology for in vivo application. Primary Aim: (1) To collect data to develop imaging algorithms to distinguish between normal and cancerous upper aerodigestive mucosa. Secondary Aims: 1. To compare the combination of wide-field fluorescence/reflectance and high resolution fluorescence microscopy images of upper aerodigestive epithelium to histopathologic analysis of biopsied tissue. 2. To compare the ability of sequential wide-field/fluorescence microscopy imaging to discriminate between normal and cancerous oral cavity mucosa with that of white-light images obtained after staining with toluidine blue.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects with biopsy-proven squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx.
- •Must be receiving surgical treatment for their cancer.
Exclusion Criteria
- •Presence of medical or psychiatric condition affecting ability to give voluntary, informed consent.
Outcomes
Primary Outcomes
Accuracy and Interrater Reliability of HRME Image Interpretation
Time Frame: baseline
We will ask blinded raters to classify the HRME images as either benign (normal) or dysplastic/cancerous (abnormal)